Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription 25.08.2025 1 AIDS 2 AIDS Res Hum Retroviruses 1 Am J Med 2 BMC Neurol 5 Clin Infect Dis 5 HIV Med 1 Int J Cancer 9 J Acquir Immune Defic Syndr 3 J Infect Dis 1 J Med Virol 2 J Virol 2 JAMA 1 Lancet Infect Dis 1 Nat Med 1 Nat Ment Health 2 Pediatr Infect Dis J 1 PLoS Med 11 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A 1 Vaccine

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. YU X, Carter M, Gao D, Nguyen N, et al
   Screening benefits for breast and colorectal cancer-specific survival among medicare enrollees with HIV.
   AIDS. 2025 Aug 19. doi: 10.1097/QAD.0000000000004325.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

2. HAHN PA, Shandilya S, da Costa LAB, da Silva LCF, et al
   The Immunogenicity of AAV-Encoded HIV-1 bNAbs in Rhesus Macaques Is Unaffected by a Short Course of the Immunomodulator CTLA4Ig.
   AIDS Res Hum Retroviruses. 2025 Aug 20. doi: 10.1177/08892229251370763.
   PubMed         Abstract available
   
   
3. SHIVAKOTI R, Letsoalo M, Lewis L, Mckinnon LR, et al
   Circulating Short-Chain Fatty Acids: Association with Vaginal Microbiota, Genital Inflammation, and HIV Acquisition.
   AIDS Res Hum Retroviruses. 2025 Aug 14. doi: 10.1177/08892229251366174.
   PubMed         Abstract available
   
   

   
   Am J Med

4. SANTHARAM Y, Chrystman A, Aung WM
   Unprotected Sex and Unusual Sepsis: Campylobacter Bacteremia in AIDS.
   Am J Med. 2025 Aug 13:S0002-9343(25)00535-2. doi: 10.1016/j.amjmed.2025.
   PubMed        
   
   

   
   BMC Neurol

5. NING Y, Liang H, Liang S, Liang X, et al
   Central nervous system infections in patients with anti-interferon-gamma autoantibodies: case series and review of the literature.
   BMC Neurol. 2025;25:345.
   PubMed         Abstract available
   
   
6. XULU K, Shezi N, Enicker B
   The management outcomes of chronic subdural hematoma in HIV-Infected individuals.
   BMC Neurol. 2025;25:341.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

7. POORE H, Wambi P, Nkereuwem E, Nakafeero J, et al
   The three-gene Xpert Host Response signature for pediatric tuberculosis screening: A prospective diagnostic accuracy study.
   Clin Infect Dis. 2025 Aug 21:ciaf445. doi: 10.1093.
   PubMed         Abstract available
   
   
8. ZHANG L, Wu X, He Y, Song Y, et al
   Impact of different INSTIs on BMI among people living with HIV who newly started ART in Shenzhen, China: a real-world data analysis.
   Clin Infect Dis. 2025 Aug 20:ciaf466. doi: 10.1093.
   PubMed         Abstract available
   
   
9. PARK SY, Takayama C, Ryu J, Sattah M, et al
   Design and evaluation of next-generation HIV genotyping for detection of resistance mutations to 28 antiretroviral drugs across five major classes including lenacapavir.
   Clin Infect Dis. 2025 Aug 19:ciaf458. doi: 10.1093.
   PubMed         Abstract available
   
   
10. COBURN SB, Silverberg MJ, Lang R, Lesko C, et al
    Clinical predictors and incidence of Kaposi sarcoma among males with HIV in the Treat-all era in the United States and Canada.
    Clin Infect Dis. 2025 Aug 18:ciaf446. doi: 10.1093.
    PubMed         Abstract available
    
    
11. NEANT N, Le MP, Bouchet S, Lagoutte-Renosi J, et al
    Therapeutic Drug Monitoring of Long-Acting Cabotegravir and Rilpivirine in a National Cohort of People With Human Immunodeficiency Virus Type 1: First Results From the ANRS-MIE CARLAPOP Study.
    Clin Infect Dis. 2025 Aug 18:ciaf385. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    HIV Med

12. KEANE A, Haberl L, Aho I, Bernardi S, et al
    European Guidelines on HIV and breastfeeding: "Same, same, but different" - Results from a WAVE survey.
    HIV Med. 2025 Aug 25. doi: 10.1111/hiv.70072.
    PubMed         Abstract available
    
    
13. CACHO J, Nomah DK, Egri N, Cofan F, et al
    Cellular and humoral response after mRNA SARS-CoV-2 vaccination in kidney transplant recipients living with HIV: A cross-sectional study.
    HIV Med. 2025 Aug 25. doi: 10.1111/hiv.70087.
    PubMed         Abstract available
    
    
14. WENDT GW, Chaves LW, Costa AB
    Exploring the influence of age, gender, stigma, and years living with HIV on mental health outcomes.
    HIV Med. 2025 Aug 19. doi: 10.1111/hiv.70098.
    PubMed         Abstract available
    
    
15. GRIFFIN DWJ, McMahon JH, Ruschena DA, Hoy JF, et al
    Solid organ transplantation in people with HIV: Outcomes, obstacles and opportunities.
    HIV Med. 2025 Aug 15. doi: 10.1111/hiv.70099.
    PubMed         Abstract available
    
    
16. CLIFTON B, Keen P, Trevillyan J, Sullivan N, et al
    Strategies to achieve the UNAIDS 95% HIV diagnosis target in Australia: Insights from a multidisciplinary roundtable.
    HIV Med. 2025 Aug 15. doi: 10.1111/hiv.70083.
    PubMed         Abstract available
    
    

    
    Int J Cancer

17. HAAS CB, Ocampo R, Liu D, Zuniga M, et al
    Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica.
    Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70082.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

18. D'ANTONI ML, Boopathy AV, Andreatta K, Chang S, et al
    HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate Through the Open-Label Extension of the ALLIANCE Study.
    J Acquir Immune Defic Syndr. 2025 Aug 26. doi: 10.1097/QAI.0000000000003749.
    PubMed        
    
    
19. QIAN Y, Comulada WS, Hidalgo MA, Lee SJ, et al
    Depression improves the predictive accuracy of the VACS Index 2.0 for all-cause mortality among sexual minority men living with HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2025 Aug 26. doi: 10.1097/QAI.0000000000003752.
    PubMed         Abstract available
    
    
20. MADLALA HP, Jao J, Roussos G, Mendham AE, et al
    Gluteal adipose tissue mitochondrial respiration and insulin sensitivity in pregnant South African women living with HIV on Tenofovir-Lamivudine-Dolutegravir.
    J Acquir Immune Defic Syndr. 2025 Aug 26. doi: 10.1097/QAI.0000000000003755.
    PubMed         Abstract available
    
    
21. BERRY DL, Orr JE, Schmickl CN, DeYoung Rpsgt P, et al
    Effects of Treating Obstructive Sleep Apnea on Common Symptoms of HIV.
    J Acquir Immune Defic Syndr. 2025 Aug 26. doi: 10.1097/QAI.0000000000003753.
    PubMed         Abstract available
    
    
22. MOYO S, Yankinda EK, Hurwitz KE, Bennett K, et al
    Predictors of Concurrent Sexual Partnerships and Association with Recent HIV Infection in a Large Population-Based Survey in Botswana.
    J Acquir Immune Defic Syndr. 2025 Aug 22. doi: 10.1097/QAI.0000000000003751.
    PubMed         Abstract available
    
    
23. KALATA NL, Bello G, Pals S, Kabaghe AN, et al
    HIV Drug Resistance to Dolutegravir Among Adults Investigated for Anti-retroviral Treatment Failure in Malawi: A 2023 National Cross-sectional Survey.
    J Acquir Immune Defic Syndr. 2025 Aug 21. doi: 10.1097/QAI.0000000000003744.
    PubMed        
    
    
24. JONES J, Schneider I, Valencia R, Jenness SM, et al
    Randomized controlled trial of a HIV prevention app to increase pre-exposure prophylaxis uptake among gay and bisexual men who have sex with men in the United States: The HealthMindr PrEP study.
    J Acquir Immune Defic Syndr. 2025 Aug 19. doi: 10.1097/QAI.0000000000003747.
    PubMed         Abstract available
    
    
25. YANG G, Dale I, Zarwell M, Elkins JS, et al
    Harnessing Egocentric Networks to Inform an Enhanced Social Network Strategy in a Southern US "Ending the HIV Epidemic" Region.
    J Acquir Immune Defic Syndr. 2025 Aug 19. doi: 10.1097/QAI.0000000000003750.
    PubMed         Abstract available
    
    
26. CHANG GC, Bingham T, Patel HK, Mungai E, et al
    Undetectable HIV-1 viral load among virally suppressed people living with HIV: implications for Undetectable equals Untransmittable (U=U) in resource-limited settings using dried spot testing.
    J Acquir Immune Defic Syndr. 2025 Aug 15. doi: 10.1097/QAI.0000000000003745.
    PubMed         Abstract available
    
    

    
    J Infect Dis

27. RUTAKINGIRWA MK, Ssebambulidde K, Okurut S, Kwizera R, et al
    Cerebrospinal Fluid Mononuclear Cell Phenotype and Activation Predictors of 2-week and 1-year survival among Persons with HIV-Associated Cryptococcal Meningitis.
    J Infect Dis. 2025 Aug 21:jiaf449. doi: 10.1093.
    PubMed         Abstract available
    
    
28. KELLER MJ, Wang T, Murphy K, Serrano MG, et al
    Cervicovaginal Secretions in Young Women with Bacterial Vaginosis Enhance HIV Infection.
    J Infect Dis. 2025 Aug 21:jiaf444. doi: 10.1093.
    PubMed         Abstract available
    
    
29. JUDSON SD, Orkin CM, Gebo K
    Mpox: What Have We Learned and How Do We Better Prepare for the Future?
    J Infect Dis. 2025;232:270-273.
    PubMed         Abstract available
    
    

    
    J Med Virol

30. BERTONI C, Diotallevi S, Lolatto R, Piromalli G, et al
    Hepatitis B Viral Rebound in People With HIV Under HBV-Active Antiretroviral Therapy.
    J Med Virol. 2025;97:e70573.
    PubMed         Abstract available
    
    

    
    J Virol

31. ZHANG H, Deng X, Dai R, Fu J, et al
    Inadequate immune response to inactivated COVID-19 vaccine among older people living with HIV: a prospective cohort study.
    J Virol. 2025 Aug 21:e0068825. doi: 10.1128/jvi.00688.
    PubMed         Abstract available
    
    
32. MESA KA, Li SW, Hutchinson JM, O'Rourke S, et al
    Parallel evolution of the elite neutralizer phenotype in divergent HIV-1 clades.
    J Virol. 2025 Aug 21:e0043325. doi: 10.1128/jvi.00433.
    PubMed         Abstract available
    
    

    
    JAMA

33. ANDERER S
    Measles Resurgence Puts People With HIV at Risk.
    JAMA. 2025 Aug 22. doi: 10.1001/jama.2025.11011.
    PubMed        
    
    
34. CHAN PA, Nunn AS
    Grant Terminations in the US Threaten HIV Research and Future Progress.
    JAMA. 2025 Aug 21. doi: 10.1001/jama.2025.12688.
    PubMed        
    
    

    
    Lancet Infect Dis

35. LADHANI SN, Ramsay ME, Fifer H
    What can be learnt from the world's first national vaccination programme against gonorrhoea.
    Lancet Infect Dis. 2025 Aug 20:S1473-3099(25)00468.
    PubMed        
    
    

    
    Nat Med

36. BOTEY-BATALLER J, van Unen N, Blaauw M, Vos WAJW, et al
    Genetic and molecular landscape of comorbidities in people living with HIV.
    Nat Med. 2025 Aug 20. doi: 10.1038/s41591-025-03887.
    PubMed         Abstract available
    
    

    
    Nat Ment Health

37. COELHO DRA, Njiro BJ, Yussuf MH, Mikomangwa WP, et al
    Cognitive behavioral therapy for antiretroviral therapy adherence and treatment outcomes among people living with HIV: a systematic review and meta-analysis.
    Nat Ment Health. 2025;3:735-746.
    PubMed         Abstract available
    
    

    
    Pediatr Infect Dis J

38. BURKHARDT I, Ruswa N, Iitana M, Ekandjo H, et al
    Epidemiology and Outcomes of Pediatric Multidrug-resistant Tuberculosis in Namibia: A Retrospective Review of National Registry Data From 2013 to 2023.
    Pediatr Infect Dis J. 2025 Aug 6. doi: 10.1097/INF.0000000000004933.
    PubMed         Abstract available
    
    
39. LOMBAARD J, Ssali F, Moolasart V, Guarino A, et al
    Pharmacokinetics, Safety, Tolerability and Antiviral Activity of Switching to Oral Rilpivirine in Combination With Other Antiretroviral Therapy in Virologically Suppressed Children Living With HIV-1 Infection: Forty-eight-week Results From the Phase 2
    Pediatr Infect Dis J. 2025 Aug 13. doi: 10.1097/INF.0000000000004943.
    PubMed         Abstract available
    
    

    
    PLoS Med

40. TOH W, Lepine A, Gueye K, Fall MM, et al
    Effect of pre-exposure prophylaxis on risky sexual behaviour of female sex workers in Dakar, Senegal: A randomised controlled trial.
    PLoS Med. 2025;22:e1004458.
    PubMed         Abstract available
    
    

    
    PLoS One

41. GAN YN, Zaki R, Hafidzar SA, Koh KC, et al
    Development and evaluation of an online HIV pre-exposure prophylaxis (PrEP) training program for community pharmacists to implement pharmacy-led PrEP services in Malaysia.
    PLoS One. 2025;20:e0328713.
    PubMed         Abstract available
    
    
42. STUART L, Alford K, Vera JH
    Correction: Non-pharmaceutical interventions for people living with HIV with cognitive impairment: A scoping review.
    PLoS One. 2025;20:e0330546.
    PubMed         Abstract available
    
    
43. DUMCHEV K, Stepanovich-Falke A, Lunchenkov N, Rohde A, et al
    Comparison of registered and survey-based modes of HIV transmission in 2021-2023: Cross-sectional study in the Kyrgyz Republic.
    PLoS One. 2025;20:e0330210.
    PubMed         Abstract available
    
    
44. MAENETJE N, Oladimeji M, Mlotshwa M, Hoft D, et al
    Epidemiological factors associated with immunological resistance in household contacts exposed to active tuberculosis in South Africa: A logistic regression analysis.
    PLoS One. 2025;20:e0329562.
    PubMed         Abstract available
    
    
45. PEIFER SJ, Moore DM, Lee R, Feaster DJ, et al
    HIV knowledge and reported stigma among South Florida health fair participants.
    PLoS One. 2025;20:e0329665.
    PubMed         Abstract available
    
    
46. MEDEIROS JA, Borges U, Wilde P, Medeiros RCDSC, et al
    Acute effect of transcutaneous auricular vagus nerve stimulation on cardiac vagal activity in men living with HIV: A proof-of-concept clinical trial.
    PLoS One. 2025;20:e0326793.
    PubMed         Abstract available
    
    
47. JONES MA, Weinstein ER, Safren SA
    Multiple marginalized identities and internalized HIV stigma among people living with HIV in South Florida: An intersectional approach.
    PLoS One. 2025;20:e0329966.
    PubMed         Abstract available
    
    
48. KARBASI AB, Iloegbu C, Ruan C, Osei-Tutu N, et al
    Syndemic interactions between HIV/AIDS, mental health conditions, and non-communicable diseases in sub-Saharan Africa: A scoping review of contributing factors.
    PLoS One. 2025;20:e0328515.
    PubMed         Abstract available
    
    
49. TUYISHIME E, Kayitesi C, Remera E, Malamba SS, et al
    Estimating the size of hard to sample populations: A comprehensive study on female sex workers and sexually exploited minors in Rwanda using privatized network sampling in 2023.
    PLoS One. 2025;20:e0329772.
    PubMed         Abstract available
    
    
50. JIN Y, Lu R, Wang M, Xu Z, et al
    Analysis of blood screening strategies and their efficacy among voluntary blood donors in a region of East China.
    PLoS One. 2025;20:e0331027.
    PubMed         Abstract available
    
    
51. STERNBERG CA, Chery MJ, Beauvoir M, Jean P, et al
    Bon bagay (good stuff): A faith-based outlook on biomedical prevention among Haitians and Haitian Americans.
    PLoS One. 2025;20:e0330852.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

52. TANG Y, Xie L, Shabangu CS, Li D, et al
    Persistent type I interferon signaling within the brain of people with HIV on ART with cognitive impairment.
    PLoS Pathog. 2025;21:e1013411.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

53. GU F, Naghavi MH
    Negative interplay between HIV-1 Gag and amyloid precursor protein centers around competition for VPS4A and TSG101.
    Proc Natl Acad Sci U S A. 2025;122:e2503988122.
    PubMed         Abstract available
    
    

    
    Vaccine

54. YOU D, Quan J, Bishai D, Lam WWT, et al
    Evaluating cost-effectiveness of 9-valent HPV vaccination for men who have sex with men by HIV status in Hong Kong.
    Vaccine. 2025;63:127625.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.